- Open
- 6.00
- High
- 6.25
- Low
- 5.76
- Close
- 5.76
- Change
- -0.25 (-4.35%)
- Volume
- 311,612
| 15 Oct 2026 | 07:00:07 | Change of Registered Office |
| 22 Sept 2026 | 07:00:05 | Trading Statement |
| 24 Aug 2026 | 07:00:09 | Appointment of Interim CFO |
| 27 Jul 2026 | 07:00:09 | Holding(s) in Company |
| 16 Dec 2025 | Annual Report and Accounts (to 2025-06-30) | |
| 17 Dec 2024 | Annual Report and Accounts (to 2024-06-30) | |
| 12 Dec 2023 | Annual Report and Accounts (to 2023-06-30) |
Skinbiotherapeutics PLC is a biotechnology company focused on developing products that enhance skin health. The company utilizes its SkinBiotix® technology, which is based on research by Professor Catherine O'Neill and Professor Andrew McBain. Skinbiotherapeutics operates through multiple subsidiaries, including AxisBiotix Limited, Dermatonics Ltd, and Bio-Tech Solutions Ltd, and aims to serve various markets within the skincare industry.
| 15 Oct 2026 | 07:00:07 | Change of Registered Office |
| 22 Sept 2026 | 07:00:05 | Trading Statement |
| 24 Aug 2026 | 07:00:09 | Appointment of Interim CFO |
| 27 Jul 2026 | 07:00:09 | Holding(s) in Company |
| 16 Dec 2025 | Annual Report and Accounts (to 2025-06-30) | |
| 17 Dec 2024 | Annual Report and Accounts (to 2024-06-30) | |
| 12 Dec 2023 | Annual Report and Accounts (to 2023-06-30) |
Skinbiotherapeutics PLC is a biotechnology company focused on developing products that enhance skin health. The company utilizes its SkinBiotix® technology, which is based on research by Professor Catherine O'Neill and Professor Andrew McBain. Skinbiotherapeutics operates through multiple subsidiaries, including AxisBiotix Limited, Dermatonics Ltd, and Bio-Tech Solutions Ltd, and aims to serve various markets within the skincare industry.
| 21 Jul 2026 |
| 07:00:03 |
| Holding(s) in Company |
| 21 Jun 2026 |
| AIM weekly movers: Qunatum Helium confirms helium concentrations and discovers oil |
| 16 Jun 2026 | AIM movers: Tatton Asset Management continues to beat expectations and Everyman Media wants to leave AIM |
| 29 Mar 2026 | AIM movers: Burford Capital case judgement overturned |
| 13 Mar 2026 | AIM movers: Atome agrees debt finance and strategic investors for Reabold Resources |
| 7 Mar 2026 | AIM weekly movers: Surface Transforms future appears bleak |
| 1 Mar 2026 | AIM weekly movers: Anglesey Mining debt settlement |
| 21 Jul 2026 |
| 07:00:03 |
| Holding(s) in Company |
| 21 Jun 2026 |
| AIM weekly movers: Qunatum Helium confirms helium concentrations and discovers oil |
| 16 Jun 2026 | AIM movers: Tatton Asset Management continues to beat expectations and Everyman Media wants to leave AIM |
| 29 Mar 2026 | AIM movers: Burford Capital case judgement overturned |
| 13 Mar 2026 | AIM movers: Atome agrees debt finance and strategic investors for Reabold Resources |
| 7 Mar 2026 | AIM weekly movers: Surface Transforms future appears bleak |
| 1 Mar 2026 | AIM weekly movers: Anglesey Mining debt settlement |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £1.94bn | +0.5% | |
| £24m | -0.6% | |
| £17m | +1.8% | |
SBTXSkinbiotherapeutics PLC | £15m | -0.6% |
| £11m | +0.0% | |
| £10m | -0.2% |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £1.94bn | +0.5% | |
| £24m | -0.6% | |
| £17m | +1.8% | |
SBTXSkinbiotherapeutics PLC | £15m | -0.6% |
| £11m | +0.0% | |
| £10m | -0.2% |
